Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.54 +0.07 (+14.77%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Amortizatization of Intangibles (2023 - 2026)

Pasithea Therapeutics (KTTA) posted Amortizatization of Intangibles of $157541.0 for Q1 2026, little changed sequentially from $157541.0 in Q4 2025, and little changed YoY from $157541.0 in Q1 2025.

Pasithea Therapeutics (KTTA) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends

Pasithea Therapeutics has reported Amortizatization of Intangibles for 4 years, with the latest figure at $157541.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles changed 0.0% year-over-year to $157541.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $630164.0 (changed 0.0% YoY) and the FY2025 annual result came in at $630164.0, changed 0.0% from the prior year.
  • Amortizatization of Intangibles steadied at $157541.0 in Q1 2026 per KTTA's latest filing, from $157541.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $157541.0 in Q1 2023 and troughed at $157541.0 in Q1 2023.
  • A 4-year average of $157541.0 and a median of $157541.0 in 2023 frame the typical range for Amortizatization of Intangibles.
  • The widest YoY moves for Amortizatization of Intangibles: up 0.0% in 2024, down 0.0% in 2024.
  • Over 4 years, Amortizatization of Intangibles stood at $157541.0 in 2023, then changed by 0.0% to $157541.0 in 2024, then changed by 0.0% to $157541.0 in 2025, then changed by 0.0% to $157541.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $157541.0, $157541.0, and $157541.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Pasithea Therapeutics 16.97 Mn 16.97 Mn - 157,541.00

Historic Data

Download Data
DateValue
Mar 31, 2026 157,541.00
Mar 31, 2026 157,541.00
Dec 31, 2025 157,541.00
Dec 31, 2025 157,541.00
Sep 30, 2025 157,541.00
Sep 30, 2025 157,541.00
Jun 30, 2025 157,541.00
Jun 30, 2025 157,541.00
Mar 31, 2025 157,541.00
Mar 31, 2025 157,541.00
Dec 31, 2024 157,541.00
Dec 31, 2024 157,541.00
Sep 30, 2024 157,541.00
Sep 30, 2024 157,541.00
Jun 30, 2024 157,541.00
Jun 30, 2024 157,541.00
Mar 31, 2024 157,541.00
Mar 31, 2024 157,541.00
Dec 31, 2023 157,541.00
Dec 31, 2023 157,541.00